Retatrutide Comparison Guide

Retatrutide (often shortened to Reta) is referenced in metabolic research literature as a triple agonist peptide framework targeting GLP-1, GIP, and glucagon receptor pathways in preclinical models. VaultLabs catalogs it as GLP-3 RT in 10 mg and 20 mg presentations — distinct from the RETA/CAG retatrutide + cagrilintide blend.

Type: Multi-receptor agonist peptide (research literature)

CJC-1295 is a GHRH analog studied in growth hormone secretagogue literature — distinct receptor profile from retatrutide.

Ipamorelin is a selective GHRP-class pentapeptide — compare secretagogue vs multi-agonist literature separately.

See /research/tirzepatide for independent encyclopedia documentation.

See /research/semaglutide for independent encyclopedia documentation.

See /research/reta-cag for independent encyclopedia documentation.

Use the peptide stack planner for educational multi-compound review: /tools/peptide-stack-planner

Compare supplier documentation standards: /compare